Trials / Completed
CompletedNCT03853135
Assessment of Endocan Serum Levels in Patients With Behcet Disease
Assessment of Endocan Serum Levels in Patients With Behcet Disease: Relation to Clinical Parameters and Disease Status
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 84 (actual)
- Sponsor
- Benha University · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Accepted
Summary
The aim of our study was to assess serum endocan levels in patients with Behcet disease and to correlate it with various disease clinical and laboratory parameters of disease activity as well as carotid intima media thickness.
Detailed description
This study will be carried out on two groups: • Group (I): Forty two patients diagnosed to have Behcets disease fulfilling the International Criteria for BD . Group (II): including 42 age and sex matching healthy volunteers as control group. (A) Clinical evaluation 1. Complete history taking. 2. Thorough clinical examination including opthalmologic evaluation . 3. Disease activity using The Behcet's disease current activity form (BD-DAF) . (B) Laboratory assessment: All patients will be subjected to the following measurements: 1. ESR 2. CRP 3. CBC 4. liver and kidney function tests d) Serum Endocan level e)triglycrides f) cholestrol C) carotid intima media thickness
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | measurement of serum endocan | measurement of serum levels of endocan |
Timeline
- Start date
- 2019-02-27
- Primary completion
- 2019-12-16
- Completion
- 2019-12-16
- First posted
- 2019-02-25
- Last updated
- 2020-01-06
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03853135. Inclusion in this directory is not an endorsement.